Daptomycin Market Players, Size, Share, Analysis and Forecast-2030

Daptomycin Market

The Daptomycin Market is anticipated to grow at a robust CAGR of 3.90%. Therefore, the market value will further increase up to USD 3.90 Billion in the studied forecast period 2022-2030.

Daptomycin is a cyclic lipopeptide antibiotic derived from the organism Streptomyces rose sports. Daptomycin is used for the treatment of various bacterial infections caused by gram-positive bacteria.

The growth of the global daptomycin market can be attributed to the high demand of daptomycin due to rising infections in the bloodstream, and increasing complicated skin and skin structure infections.

Furthermore, the rise of right-sided infective endocarditis, and daptomycin as an antibacterial drug, a bacterial metabolite and a member of calcium-dependent antibiotics, are also expected to fuel the market growth during the forecast period.

However, increasing rates of infection with gram-positive bacteria and the rapid emergence of resistance to the new agent are expected to restrain the growth of the global daptomycin market.

Several market players such as Cipla, Pfizer, and Dr. Reddy’s Laboratories among others currently dominate the global daptomycin market.

Major Key Players:

Some of the daptomycin market players are Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co (US), Cipla (India), Pfizer (US), BE Pharmaceuticals (US), Dr. Reddy’s Laboratories (India), Mylan (US), Fresenius Kabi (Germany), Nichi-Iko Pharmaceutical (Japan), Novo Holdings A/S (Denmark), Zhejiang Hisun (China), Hengrui Medicine (China), Huadong Medicine (China), Civica Rx (US).

Segment Analysis

Global Daptomycin Market has been segmented based on Indication, Age Group, and Strength.

Based on indication, the global daptomycin market has been segmented into complicated skin structure infections, bacteremia, and others. The complicated skin structure infections are expected to be the fastest-growing segment during the forecast period.

Based on the age group, the market has been segmented into pediatric and adult. The adult segment is expected to hold the largest market share with an increasing number of bacteremia and right-sided infective endocarditis patients.

Based on strength, the market is segmented into 350 mg and 500 mg.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2020, owing to the rising complicated skin and skin structure infections in the region. The daptomycin market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European daptomycin market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The daptomycin market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. Due to rising infections in the bloodstream in the region, the market in Asia-Pacific is expected to be the fastest-growing. The daptomycin market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

New-Born Screening Market Players, Size, Share, Trends, Opportunities, Growth Analysis and Forecast to 2032

New-Born Screening Market Newborn screening is the practice of testing every newborn for some harmful or possibly fatal disorders that are not otherwise obvious at birth. New-born screening involves the use of various devices for the screening procedure. Diseases such as phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell disease, cystic fibrosis, tyrosinemia, and other such disorders can be screened using new-born screening devices. The rising prevalence of neonatal conditions and government support along with new-born screening programs have led to the growth of the new-born screening market in recent years. Additionally, increasing neonatal population and technological advancements are likely to contribute to the growth of the market over the assessment period. The new-born screening market is projected to reach USD 1.02 Billion by 2032 at 8.20% CAGR during the forecast period 2023-2032 The key factors driving the market growth are increasing spending by g
Read more

Patient Registry Software Market: A Regional Overview

In an era of data-driven healthcare, patient registry software has emerged as a pivotal tool for healthcare professionals, researchers, and policymakers. These platforms enable the efficient collection, management, and analysis of patient data to improve care quality, enhance clinical research, and address public health concerns. This article explores the Patient Registry Software Market, offering a comprehensive regional perspective on its growth and significance. The global patient registry software market has been on a steady rise due to the increasing importance of evidence-based medicine and the continuous quest for enhanced patient outcomes. These software solutions have become essential in capturing patient data, streamlining patient management, tracking disease prevalence, and facilitating clinical research. As the demand for integrated healthcare solutions grows, patient registry software is witnessing substantial adoption across the world. Its value extends beyond indivi
Read more

Veterinary Medicine Market Forecast to 2032: Trends, Analysis & Growth Projections

The Veterinary Medicine Market is expected to reach USD 44.92 billion at CAGR of 5.6% during the forecast period of 2023 to 2032 . The Veterinary Medicine market is a dynamic and rapidly evolving sector that plays a pivotal role in safeguarding the health and well-being of animals. With a growing emphasis on preventive healthcare and advancements in veterinary science, the market is witnessing significant expansion. Veterinary science, encompassing a wide range of medical disciplines dedicated to animal care, forms the cornerstone of this market's growth. One notable trend within the Veterinary Medicine market is the rise of holistic veterinary medicine . This approach goes beyond traditional medical practices, considering the overall well-being of animals by addressing not only physical ailments but also emotional and environmental factors. Holistic veterinary medicine integrates various therapeutic modalities, including acupuncture, herbal medicine, and nutritional counselli
Read more